Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: a rapid steroid withdrawal protocol.
暂无分享，去创建一个
S. Teraoka | S. Fuchinoue | M. Nakamura | I. Nakajima | T. Tojimbara | S. Sato | K. Kai | T. Kawase | T. Ando
[1] L. Rostaing,et al. Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation. , 2003, Transplantation.
[2] S. Teraoka,et al. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis , 2002, Transplantation.
[3] Y. Yamaguchi,et al. ANTI-AB TITER CHANGES IN PATIENTS WITH ABO INCOMPATIBILITY AFTER LIVING RELATED KIDNEY TRANSPLANTATIONS: Survey of 101 Cases to Determine Whether Splenectomies Are Necessary for Successful Transplantation , 2000, Transplantation.
[4] T. Yagisawa,et al. ABO-incompatible kidney transplantation in a single-center trial. , 1993, Transplantation proceedings.